Novel surgical glue moves closer to FDA application

09/16/2011 | Pittsburgh Post-Gazette · American City Business Journals

European Union officials approved the sale of a surgical glue that the manufacturer says reduces fluid accumulation and reduces the need for drainage of surgical wounds. TissuGlu is dispensed through a handheld applicator and adheres the skin flap to tissue, closing spaces where fluid can build up. Manufacturer Cohera Medical plans to file for FDA approval by the end of the year and begin clinical trials early next year.

View Full Article in:

Pittsburgh Post-Gazette · American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC